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Background: The human HFE gene (a key component of iron homeostasis in humans) is 
involved in hereditary hemochromatosis, a common autosomal recessive genetic dis-
order that is characterized by excessive intestinal iron absorption and progressive iron 
overload. 
Objectives: In this study, we assessed the frequency of two common forms of hemochro-
matosis HFE gene mutation (C282Y and H63D) in patients suﬀering from cryptogenic 
cirrhosis.
Patients and Methods: One hundred and ﬁfty individuals were included in this study, in 
which 100 were patients with cryptogenic cirrhosis and 50 were from the normal popu-
lation. All individuals were examined for common HFE gene mutations by ampliﬁcation 
of nucleotide 845 C282Y and 187 H63D alleles and product analysis using the polymerase 
chain reaction method and restriction enzyme digestion.
Results: No case of either a homozygous or heterozygous C282Y mutation was found. For 
the H63D mutation, no homozygosity was detected but heterozygosity was detected in 
22% of patients and in 28% of the normal population.
Conclusions: Hereditary hemochromatosis is not a major cause of cryptogenic cirrhosis 
in the Iranian population.
Hepat Mon.2011;11(11):887-889. DOI: 10.5812/kowsar.1735143x.781
1. Background
Hereditary hemochromatosis (HH) is an autosomal 
recessive condition associated with over-absorption of 
iron from the intestine and its accumulation in solid or-
gan parenchyma, particularly in the liver, pancreas, and 
heart (1). Feder et al. (1996) described a candidate gene 
on the short arm of chromosome 6, which they named 
the HFE gene, and identiﬁed it as the cause of hemochro-
matosis (2). In Western populations, the 2 most common 
variants detected in this gene, C282Y and H63D, are re-
lated to iron overload (3). Clinical consequences of iron 
overload include cirrhosis of the liver, cardiac failure, 
and pancreatic disease (4).
2.Objectives
To the best of our knowledge, there are no published 
studies on the frequency and probable role of HFE muta-
tions in cryptogenic cirrhosis. Therefore, we performed 
this study to examine the frequency of 2 common muta-
tions of the HFE gene in patients with cryptogenic cirrho-
sis in the Iranian population.888  Hereditary Hemochromatosis Jowkar Z et al.
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3. Patients and Methods
3.1. Patients
In this prospective study, 100 patients with cryptogenic 
cirrhosis and on a waiting list for a liver transplant were 
selected. Viral markers and autoimmune markers were 
negative in these patients. Work up for α-1 antitrypsin 
deﬁciency and Wilson’s disease were also negative. No 
history of drug abuse, toxin, or alcoholism was noted. 
Triglyceride and cholesterol levels were normal in indi-
viduals from the control and cirrhotic groups.
Fifty normal, unrelated healthy individuals (49 male 
and 1 female blood donors) aged 21–61 years (36.98 ± 10) 
were selected as the control group, all of whom had nor-
mal liver function tests. Viral markers were negative in 
this group. The age of individuals in this group was simi-
lar to that of the patient group, but the gender composi-
tion of the groups was diﬀerent because there are very 
few female blood donors in our region.
3.2 Methods
A 10-mL sample of fasting blood was collected from 
each patient for HFE gene mutation analysis, biochemi-
cal analysis, and to measure transferrin saturation (TS). 
DNA was extracted from blood leukocytes using a DNA 
isolation kit (Qiagen Company , USA). Polymerase chain 
reaction-restriction fragment length polymorphism 
(PCR-RFLP) analysis was then performed (Figure 1).
4. Results
Among the 100 patients with cryptogenic cirrhosis 
that were examined, we found no homozygotes or het-
erozygotes for C282Y. Although no homozygote case was 
detected for H63D, 22 of the patients (22%) were hetero-
zygous for H63D. In the control group, 14 patients (28%) 
were heterozygous for H63D but no homozygote cases 
were detected. Further, no C282Y mutation, either ho-
mozygous or heterozygous, was found. Table 1 shows the 
HFE gene mutation status of the two control groups and 
of cirrhotic patients in the iron-overloaded and normal 
groups. As indicated in Table 1, most of the cirrhotic pa-
tients and controls with heterozygous mutations had a 
normal iron load.
5. Discussion
Hereditary Hemochromatosis (HH) is a genetic disor-
der, the prevalence of which varies in diﬀerent ethnic 
groups. The expression of HH is modiﬁed by several fac-
tors, including dietary iron intake and blood loss associ-
ated with menstruation, pregnancy, and blood donation 
(5). The gene responsible in the majority of patients with 
this disorder (the HFE gene) has been identiﬁed on the 
short arm of chromosome 6, and encodes a 343-amino 
acid protein (6). Thirty-seven allelic variants of HFE gene 
mutations have been identiﬁed. Two of the missense mu-
tations that are found in the majority of patients with 
HH are C282Y and H63D (3). The frequency of the most 
common HFE genotype diﬀers in diﬀerent geographic 
locations (7). In this study, we investigated the probable 
association of HFE gene mutations in a group of patients 
with cryptogenic cirrhosis. As shown in Table 2, no ho-
mozygous cases of either C282Y or H63D were detected 
and only 22% of the patients were heterozygous for H63D, 
Figure 1. The PCR of the Results of Normal and Heterozygote Patients
Lanes 1, 2, 3, and 4: Normal C282Y before and after enzyme 
digestion in 2 patients; Lane 5: Negative Control; Lane 6: 
50-bp ladder; Lanes 7 and 8: H63D before and after en-
zyme digestion in a normal patient; Lanes 9 and 10: H63D 
before and after enzyme digestion in a heterozygote pa-
tient; Lane 11: 50-bp ladder.
C 282Y, No.(%) H63D, NO. (%)
No Mutation, No. (%)
Homozygote Heterozygote Homozygote Heterozygote
Patients (n = 100)
Iron overload
Normal iron
0
0
0
0
0
0
1 (1)
21 (21)
13 (13)
65 (65)
Normal controls (n = 50)
Iron overload
Normal iron
0
0
0
0
0
0
1 (2)
12 (26)
2 (4)
34 (68)
Table 1. The Frequency of HFE Gene Mutations in Two Groups of Cirrhotic Patients and Normal Blood Donors, According to the Presence or Absence of 
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which was not signiﬁcantly diﬀerent from the controls 
(28%) (P > 0.05).
To the best of our knowledge, few studies have exam-
ined the frequency of HFE gene mutations in patients 
with chronic liver diseases and cirrhosis (8). However, as 
indicated in Table 2, our results are very similar to those 
reported in India and relatively similar to those reported 
in Turkey (1, 3). Previous studies have described the preva-
lence of HFE gene mutations in the Iranian population, 
in patients with thalassemia, and in a group of diabetics 
(8-10). The results of both these studies were very similar 
to ours with regards to H63D. However, we did not ob-
serve any cases of heterozygotes for C282Y, whereas the 
frequency of heterozygotes in patients with thalassemia 
was 3% in a previous study from Iran (8-11).
In conclusion, our study suggests that iron overload 
and HFE gene mutations do not play a primary role in 
cryptogenic cirrhosis in the south Iranian population.
Acknowledgements
None declared.
Financial Disclosure
None declared.
Funding/Support
This study is granted by Shiraz University of Medical Sci-
ences as No. 87-4224.
References
1.  Simsek  H, Balaban YH, Yilmaz E, Sumer H, Buyukasik Y, Cengiz C, 
et al. Mutations of the HFE gene among Turkish hereditary he-
mochromatosis patients. Ann Hematol. 2005;84(10):646-9.
2.  Lal P,   Fernandes H, Koneru B, Albanese E, Hameed M. C282Y mu-
tation and hepatic iron status in hepatitis C and cryptogenic cir-
rhosis. Arch Pathol Lab Med. 2000;124(11):1632-5.
3.  Panigr  ahi I, Ahmad F, Kapoor R, Sharma PK, Makharia G, Saxena 
R. Evidence for non-HFE linked hemochromatosis in Asian Indi-
ans. Indian J Med Sci. 2006;60(12):491-5.
4.  Moyses   CB, Moreira ES, Asprino PF, Guimaraes GS, Alberto FL. Si-
multaneous detection of the C282Y, H63D and S65C mutations 
in the hemochromatosis gene using quenched-FRET real-time 
PCR. Braz J Med Biol Res. 2008;41(10):833-8.
5.  Bozkay  a H, Bektas M, Metin O, Erkan O, Ibrahimoglu D, Dalva 
K, et al. Screening for hemochromatosis in Turkey. Dig Dis Sci. 
2004;49(3):444-9.
6.  Leone  PE, Gimenez P, Collantes JC, Paz-y-Mino C. Analysis of HFE gene 
mutations (C282Y, H63D, and S65C) in the Ecuadorian population. 
Ann Hematol. 2005;84(2):103-5.
7.  Pietra  pertosa A, Vitucci A, Campanale D, Palma A, Renni R, Delios G, 
et al. HFE gene mutations an Apulian population: allele frequencies. 
Eur J Epidemiol. 2003;18(7):685-9.
8.  Ghazia  ni T, Alavian SM, Zali MR, Shahraz S, Agah M, Jensen KP, et al. 
Serum measures of iron status and HFE gene mutations in patients 
with hepatitis B virus infection. Hepatol Res. 2007;37(3):172-8.
9.  Jazaye ri M, Bakayev V, Adibi P, Haghighi Rad F, Zakeri H, Kalantar 
E, et al. Frequency of HFE gene mutations in Iranian beta-thal-
assaemia minor patients. Eur J Haematol. 2003;71(6):408-11.
10.  Karim  i M, Yavarian M, Delbini P, Harteveld CL, Farjadian S, Fio-
relli G, et al. Spectrum and haplotypes of the HFE hemochroma-
tosis gene in Iran: H63D in beta-thalassemia major and the ﬁrst 
E277K homozygous. Hematol J. 2004;5(6):524-7.
  11.  Shariﬁ F, Esmaeilzadeh A, Zali M. Hemochromatosis gene (HFE) 
mutations in patients with type 2 diabetes and their control 
group in an Iranian population. Saudi Med J. 2008;29(6):808-12.
  12.  Girouard J, Giguere Y, Delage R, Rousseau F. Prevalence of HFE 
gene C282Y and H63D mutations in a French-Canadian popu-
lation of neonates and in referred patients. Hum Mol Genet. 
2002;11(2):185-9.
 13.  Neghina AM, Anghel A, Sporea I, Popescu A, Neghina R, Collins A, 
et al. Mutant HFE genotype leads to signiﬁcant iron overload in 
patients with liver diseases from western Romania. J Appl Genet. 
2009;50(2):173-6.
  14.  Geier A, Reugels M, Weiskirchen R, Wasmuth HE, Dietrich CG, 
Siewert E, et al. Common heterozygous hemochromatosis gene 
mutations are risk factors for inﬂammation and ﬁbrosis in 
chronic hepatitis C. Liver Int. 2004;24(4):285-94.
  15.  Zamin I, Jr., Mattos AA, Mattos AZ, Migon E, Bica C, Alexandre CO. 
Prevalence of the hemochromatosis gene mutation in patients 
with nonalcoholic steatohepatitis and correlation with degree 
of liver ﬁbrosis. Arq Gastroenterol. 2006;43(3):224-8.
 16.  Yonal O, Hatirnaz O, Akyuz F, Ozbek U, Demir K, Kaymakoglu S, et 
al. HFE gene mutation, chronic liver disease, and iron overload 
In Turkey. Dig Dis Sci. 2007;52(11):3298-302.
  17.  Dhillon BK, Das R, Garewal G, Chawla Y, Dhiman RK, Das A, et al. 
Frequency of primary iron overload and HFE gene mutations 
(C282Y, H63D and S65C) in chronic liver disease patients in 
north India. World J Gastroenterol. 2007;13(21):2956-9.
Target of Study C282Y, % H63D, %
Heterozygote Homozygote Heterozygote Homozygote
USA (2) Cryptogenic cirrhosis 5.4 0.26 13.5 1.89
USA (12) HCV cirrhosis 11.5 0 0 0
Western Romania (13) Various liver diseases 4.8 19 9.5 0
Germany (14) Chronic hepatitis C 6.6 0 34.9 3
Brazil (15) Chronic hepatitis C 35 0 5 0
Turkey (16) Chronic liver disease 1.7 0 28 2
India (17) Chronic liver disease 0 0 14.8 0.4
India (3) Cryptogenic cirrhosis 0 0 19.3 3.2
Iran (Current study) Cryptogenic cirrhosis 0 0 22 0
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